Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistent Lyme Empiric Antibiotic Study Europe. A Prospective, Randomised Study Comparing Two Prolonged Oral Antibiotic Strategies After Initial Intravenous Ceftriaxone Therapy for Patients With Symptoms of Proven or Possible Persistent Lyme Disease

NCT01207739 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01207739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01207739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistent Lyme Empiric Antibiotic Study Europe. A Prospective, Randomised Study Comparing Two Prolonged Oral Antibiotic Strategies After Initial Intravenous Ceftriaxone Therapy for Patients With Symptoms of Proven or Possible Persistent Lyme Disease
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2010
Completion date
October 31, 2014
Enrollment
280 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

borrelia infection, lyme disease